SAGE - Sage Therapeutics appoints Laura Gault as Chief Medical Officer
- Sage Therapeutics ( NASDAQ: SAGE ) on Tuesday has appointed Laura Gault, MD, Ph.D. as Chief Medical Officer.
- In her new role, Dr. Gault will focus on advancing Sage’s current and emerging product pipeline through all stages of development.
- In her previous role, Dr. Gault was Vice President, Therapeutic Area Head for Neurology and Ophthalmology at Alexion/Astra Zeneca Rare Disease and was responsible for the development of ravulizumab in generalized myasthenia gravis and neuromyelitis optica spectrum disorder and the initiation of new programs in dermatomyositis, Guillain-Barré syndrome, geographic atrophy and gMG.
For further details see:
Sage Therapeutics appoints Laura Gault as Chief Medical Officer